Preferred Label : Perlman syndrome;
Symbol : PRLMNS;
CISMeF acronym : PRLMNS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Nephroblastomatosis, fetal ascites, macrosomia, and wilms tumor; Renal hamartomas, nephroblastomatosis, and fetal gigantism;
Description : Perlman syndrome is an autosomal recessive congenital overgrowth syndrome with similarities
to Beckwith-Wiedemann syndrome (BWS; 130650). Affected children are large at birth,
are hypotonic, and show organomegaly, characteristic facial dysmorphisms (inverted
V-shaped upper lip, prominent forehead, deep-set eyes, broad and flat nasal bridge,
and low-set ears), renal anomalies (nephromegaly and hydronephrosis), frequent neurodevelopmental
delay, and high neonatal mortality. Perlman syndrome is associated with a high risk
of Wilms tumor, with a 64% incidence in infants surviving beyond the neonatal period.
The tumor is diagnosed at an earlier age in these individuals compared with sporadic
cases (less than 2 years and 3-4 years of age, respectively), and there is a high
frequency of bilateral tumors (55%). Histologic examination of the kidneys in children
with Perlman syndrome shows frequent nephroblastomatosis, which is a precursor lesion
for Wilms tumor (summary by Astuti et al., 2012).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the DIS3 like 3'-5' exoribonuclease 2 gene (DIS3L2, 614184.0001);
Prefixed ID : #267000;
Origin ID : 267000;
UMLS CUI : C0796113;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)